BOTOX Dose B

Phase 2Small molecule

AbbVie

BOTOX Dose B is one of 12 small molecule programs targeting Ventral Hernia. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ventral HerniaActive, not recruiting

Ventral HerniaPhase 2

Active, not recruiting

Competition

Competitive Landscape

16 competitors in Ventral Hernia

#DrugCompanyPhaseTrials

Marcaine

IInnocoll

Approved

1 2

Robaxin

GGrupo Espanol de Tumores Neuroendocrinos

Approved

1 3

Xylocaine

CCitius Pharmaceuticals, Inc.

Phase 3

1 4

Botox

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 2

1 5

MOA-728

BBausch Health Americas, Inc.

Phase 3

1 6

AGN-151607-DP

AbbVie

Phase 2

1 7

Entereg

Merck & Co.

Preclinical

1 8

CA-008

CConcentric Analgesics

Phase 2

1 9

Naropin

FFresenius Kabi Oncology Ltd.

Preclinical

1 10

BOTOX Dose B

AbbVie

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Treatment1 trial

BOTOX® for the Treatment of Platysma Prominence

Completed· AbbVie logo

AbbVie·Phase 2·NCT03915067·171 enrolled

Ventral Hernia1 trial

A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique

Withdrawn· AbbVie logo

AbbVie·Phase 2·NCT05606757

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for BOTOX Dose B. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — BOTOX Dose B compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for BOTOX Dose B. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — AbbVie company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: AbbVie

BOTOX Dose B

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Treatment1 trial

Ventral Hernia1 trial

References

Drug Info

Quick Facts

Related News